Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Debt to Equity Ratio : 0.5084 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5084 |
| June 30, 2026 | 0.6967 |
| March 31, 2026 | 0.5714 |
| December 31, 2025 | 0.4082 |
| September 30, 2025 | 0.4262 |
| June 30, 2025 | 0.0623 |
| March 31, 2025 | 0.4358 |
| December 31, 2024 | 0.3051 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.1165 |
| June 30, 2024 | 0.1012 |
| March 31, 2024 | -1.581 |
| December 31, 2023 | -5.871 |
| September 30, 2023 | -3.181 |
| June 30, 2023 | -10.22 |
| March 31, 2023 | 1.329 |
| December 31, 2022 | 1.026 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Astrana Health, Inc. | 1.141 |
| Agilon Health, Inc. | 0.119 |
| Starling Oncology, Inc. | -2.750 |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 8.350 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 517.19M |
| Total Liabilities (Quarterly) | 192.92M |
| Shareholders Equity (Quarterly) | 324.28M |
| Current Ratio | 0.2278 |
| Net Debt Paydown Yield | -18.93% |